CAJ | 학술논문

目的：探讨针对盆腔炎患者，观察选择丹黄祛瘀片+微波治疗后的临床效果表现。方法选择2012年12月—2014年12月盆腔炎患者共130例。通过随机数表字法完成盆腔炎患者的随机分组。C1组（观察组65例）：奥硝唑分散片配伍丹黄祛瘀片加微波进行治疗；C2组（对照组65例）：临床选择奥硝唑分散片加微波治疗的方法。对比两组盆腔炎患者在临床治疗效果以及临床并发症等方面存在的差异。结果两组盆腔炎患者临床完成治疗后，在临床治疗总有效率方面，C1组盆腔炎患者明显高于C2组患者（P<0.05）；在临床不良反应出现概率方面，C1组盆腔炎患者明显低于C2组患者（P<0.05）。结论针对盆腔炎患者，临床选择奥硝唑分散片配伍丹黄祛瘀片加微波方式对疾病进行干预，能够获得确切的临床治疗效果，凸显奥硝唑分散片配伍丹黄祛瘀片加微波对盆腔炎疾病进行治疗的临床价值。
목적：탐토침대분강염환자，관찰선택단황거어편+미파치료후적림상효과표현。방법선택2012년12월—2014년12월분강염환자공130례。통과수궤수표자법완성분강염환자적수궤분조。C1조（관찰조65례）：오초서분산편배오단황거어편가미파진행치료；C2조（대조조65례）：림상선택오초서분산편가미파치료적방법。대비량조분강염환자재림상치료효과이급림상병발증등방면존재적차이。결과량조분강염환자림상완성치료후，재림상치료총유효솔방면，C1조분강염환자명현고우C2조환자（P<0.05）；재림상불량반응출현개솔방면，C1조분강염환자명현저우C2조환자（P<0.05）。결론침대분강염환자，림상선택오초서분산편배오단황거어편가미파방식대질병진행간예，능구획득학절적림상치료효과，철현오초서분산편배오단황거어편가미파대분강염질병진행치료적림상개치。
Objective To observe the clinical effect of Danhuang Quyu tablet and microwave treatment on patients with pelvic inflamma-tory. Methods 130 cases of patients with pelvic inflammatory disease were selected from December 2012 to December 2014. Completing randomized grouping of patients with pelvic inflammatory by random number table method. C1 group ( observation group of 65 cases) :Ornidazole dispersible tablets compatibility Danhuang Quyu tablet combined with microwave treatment; group C2 ( control group of 65 cases) : Ornidazole dispersible tablets combined with microwave therapy. Differences in the clinical treatment effect and clinical compli-cations were compared between the two groups of patients with pelvic inflammatory disease. Results After treatment, the clinical total ef-fective ratr of group C1was higher than that of C2 group, the difference was statistically significant ( P<0.05) ; the clinical adverse reac-tions of C1 group was lower than that of the C2 group, the difference was statistically significant ( P<0.05) . Conclusion For the patients with pelvic inflammatory disease, the clinical choice of Ornidazole dispersible tablets compatibility Danhuang Quyu tablets combined with microwave intervention on disease can obtain the exact curative effect, and highlight the clinical value on treatment of pelvic inflammatory disease.